期刊文献+

他汀预处理对再灌注损伤的研究进展

下载PDF
导出
摘要 心肌在血液供应阻断30min以上就会出现细胞不可逆的损伤乃至死亡,因此及时恢复心肌的血液供应被视为挽救这部分心肌的重要措施。但是部分试验研究发现,再灌注后心肌不仅功能未得到完全恢复,反而损伤加重,这就是缺血再灌注损伤。经过多年的研究与实践,对再灌注损伤的认识已得到很大的进展,其中为大家所公认的是氧自由基生成在再灌注损伤中所占的重要地位。
作者 陈淼 杨立沛
出处 《北京医学》 CAS 2009年第4期231-233,共3页 Beijing Medical Journal
  • 相关文献

参考文献14

  • 1Roberta A, Gottlieb, Katharine O, et al. Reperfusion induce sapoptosi in rabbit cardiomyocytes. J Clin Invest, 1996, 112:1621-1628.
  • 2Ruiz-Gines JA, Lopez-Ongil S, Gonzalez-Rubio M, et al. Reactive oxygen species induce proliferation of bovine aortic endothelial cells. J Cardiovasc Pharmacol, 2000, 35:109 - 113.
  • 3戴瑞鸿 李勇 范维琥 等.保护内皮细胞功能在防治心血管疾病中的重要性[J].国际心血管杂志,2000,2:328-332.
  • 4Lum H, Roebuck KA. Oxidant stress and endothelial cell dysfunction. Am J Physiol Cell Physiol, 2001, 280:719 - 741.
  • 5Leonhardt W, Karktschiev T, Meissner D, et al. Effect of fluvastation therapy on lipids, antioxidants oxidation of low density lipoproteins and trace metals. Eur J Clin Pharmacol, 1997, 53: 65- 69.
  • 6Fenster BE, Tsao PS, Rockson SG. Endothelial dysfunction: Clinical strategies for treating oxidant stress. Am Heart J, 2003, 146: 218 - 226.
  • 7鄢华,高炜.他汀类药物作用和作用机制的新认识[J].临床内科杂志,2006,23(1):5-7. 被引量:23
  • 8李卫萍,孙明,贾三庆.阿托伐他汀对自发性高血压大鼠主动脉活性氧、p22phox表达和SOD活性的影响[J].首都医科大学学报,2005,26(2):116-119. 被引量:5
  • 9Zhao JL, Yang YJ, Gao RL. Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial KATP channel. Br J Pharmaeol, 2006, 149:243 - 249.
  • 10Bell RM, Yellon DM. Atorvastatin, administered at heonset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. JACC, 2003, 41:508 - 515.

二级参考文献22

  • 1Cai H, Harrison D G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000,87:840~844.
  • 2Berry C, Humilton C A, Brosonan M J, et al. Investigation into the sources of superoxide production in human internal mammary arteries. Circulation, 2000,101:2206~2212.
  • 3Munzel T, Kurz S, Thoenes, et al. Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase: a new action for an old drug. J Clin Invest, 1996,98:1465~1470.
  • 4Hamilton C A, Brosnan M J. Superoxide excess in hypertension and aging:a common cause of endothelial dysfunction. Hypertension, 2001,37(2 pt 2):529~534.
  • 5Kerr S, Brosnan M J, Mclntyre M, et al. Superoxide anion production is increased in a model of genetic hypertension: the role of the endothlium. Hypertens, 1999,33:1353~1358.
  • 6Zalba G, Beaumont F J, José F J, et al. Vascular NADH/NADPH is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension, 2000,35:1055~1061.
  • 7Stepp DW, Ou J, Ackerman AW, et al. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol,2002 ;283 :H750-759.
  • 8Ou J,Ou Z,Jones DW,et al. L-4F,an apolipoprotein A-1 mimetic,dramatically improves vasodilation in hypercholestemlemia and sickle cell disease. Circulation ,2003,107:2337-2341.
  • 9Mason RP,Walter MF,Jacob RF. Effects of HMG-CoA reductase inhibitors on endothelial function : role of microdomains and oxidative stress.Circulation,2004,109 ( Suppl 1 ) : Ⅱ34-41.
  • 10Wassmann S, Laufs U, Stamenkovic D, et al. Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production. Circulation,2002,105:2053-2091.

共引文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部